Mirae Asset Global Investments Co., Ltd. Pacira Bio Sciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,789 shares of PCRX stock, worth $41,182. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,789
              Previous 1,548
              
        
           15.57%
        
      
          
        Holding current value
$41,182
            Previous $38,000
            
        
           10.53%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  15 transactions
	
  Others Institutions Holding PCRX
# of Institutions
259Shares Held
51MCall Options Held
289KPut Options Held
130K- 
    
      Black Rock Inc. New York, NY8.01MShares$184 Million0.01% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA5.41MShares$124 Million0.0% of portfolio
- 
    
      Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$55.1 Million0.08% of portfolio
- 
    
      D. E. Shaw & Co., Inc. New York, NY2.25MShares$51.9 Million0.04% of portfolio
- 
    
      Dimensional Fund Advisors LP Austin, TX2.15MShares$49.5 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.05B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...